▷ Discovery Life Sciences Expands Leadership Position for Rapid Global Growth …

22.10.2021 – 19:32

Discovery Life Sciences

Huntsville, Ala. (ots/PRNewswire)

Dynamic HR leader leads the company’s efforts to recruit top talent, improve global organizational development programs, and increase commitment to workplace design and inclusion

Discovery Life Sciences (TM) (Discovery), the Biospecimen and Biomarker Specialists (TM), today announced the addition of senior executives and strategic plans to its operational talent pool in the wake of increasing global demand for its products and services. The company will increase its commitment to expanding diversity as it rapidly expands its global workforce.

Katelyn Petti Hokenberg recently joined Discovery as Chief Human Resources Officer and leads Discovery’s expansion efforts that include recruiting and hiring top talent worldwide. She is committed to empowering all employees for success by implementing comprehensive programs that focus on learning and development and employee engagement while enhancing the company’s existing diversity, equity and inclusion policies.

“Employee empowerment and employee satisfaction are critical to building a team that works together and works effectively toward the common goal of helping our clients accelerate new therapies for the patients who need them,” said Hokenberg. “The growth and accomplishments of Discovery are inspiring and I am honored to have the opportunity to be a part of it.”

Hokenberg brings more than two decades of advanced human resource leadership experience to Discovery. Most recently, she led global organizational development for Merz Aesthetics, where her efforts resulted in award-winning corporate cultures and organization-wide growth. She has also created employee groups focused on women leadership, diversity and global inclusion, and corporate social responsibility.

We have an extremely talented team at Discovery. Our customers continue to confirm this with their growing demand for our employees to support their research and development programs for new diagnostics and therapies, “said Glenn Bilawsky, CEO of Discovery. When Katelyn executes our people strategy, we ensure that we remain on our inclusive Building, collaborative and learning environment. Our employees deserve the company’s commitment to develop their technical knowledge and leadership skills to help them achieve their career goals in a welcoming, productive and safe work environment. We passionately believe that our people are the source our differentiation and are essential to our aggressive growth and success. “

Discovery Life Sciences and HudsonAlpha Discovery information

Discovery Life Sciences are the biospecimen- and biomarker specialists (TM) and combine the world’s largest commercial biosample inventory and procurement network with outstanding multi-active biomarker service laboratories to accelerate precision medicine programs for cancer, infectious diseases and other rare and complex diseases. We are a leading provider of highly characterized human cellular starting materials and expert multimicrobial analysis services driving the research, development and manufacture of cell and gene therapies.

HudsonAlpha Discovery® is the sequencing and bioinformatics division of Discovery, a globally recognized service laboratory that leverages the latest genomic research technologies to provide comprehensive support for discovery, translational and clinical research.

Driven by leading scientific expertise and innovative use of the latest technologies, the Discovery team works together with its customers and advises them in order to overcome obstacles faster and obtain results for important research and development decisions at market-leading speed. We are Science at your Service (TM)! For more information, see www.dls.com.

Photo – https://mma.prnewswire.com/media/1666334/DLS_Headshots_58.jpg

Press contact:

Brian Bennett
[email protected]

Original content by: Discovery Life Sciences, transmitted by news aktuell


Leave a Reply

Your email address will not be published.